Opendata, web and dolomites

TargetDUBs SIGNED

Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TargetDUBs project word cloud

Explore the words cloud of the TargetDUBs project. It provides you a very rough idea of what is the project "TargetDUBs" about.

selectively    ub    simultaneously    profiling    modification    explore    protacs    protein    lung    shown    abundant    irreversible    probes    family    synthesize    limitations    terminal    ligase    diseases    deubiquitinases    hundreds    tool    neurodegenerative    identification    realize    deubiquitination    actual    quantification    direct    removal    brain    mechanism    regulation    ovarian    driving    carboxy    dysregulation    prevent    tissues    fibrosis    disease    quantitatively    drug    breast    therapeutic    molecules    l1    starting    uch    anticipate    overcome    dubs    vivo    proteomics    vitro    substrates    fundamental    degradation    alzheimer    biology    e3    functions    types    proteome    uchl1    proteins    cells    pathological    point    colorectal    unmet    ubiquitin    liver    cancers    regulated    cancer    selective    assisting    cellular    proteasome    paradigm    experiments    poorly    endogenous    small    degrade    headed    almost    models    emerged    prostate    inhibitors    healthy    hydrolase    enzymes    parkinson    effect    itself    discovery    therapeutics   

Project "TargetDUBs" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 224˙933 €
 EC max contribution 224˙933 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2021-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 224˙933.00

Map

 Project objective

Modification of proteins with ubiquitin (Ub), itself a small protein, is a fundamental mechanism involved in regulation of almost all cellular functions. There are hundreds of enzymes involved in the addition or removal of Ub, and this system has emerged as an important drug target in many diseases. Ubiquitin Carboxy-Terminal Hydrolase L1 (UCHL1) is a member of the UCH family of deubiquitinases (DUBs), and is the most abundant protein in the brain. UCHL1 dysregulation has been shown to be associated with neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, various types of cancers (colorectal, breast, prostate, ovarian, and lung cancers), and liver fibrosis. However, its actual functions, endogenous substrates, and how its activity is regulated in vivo, both in pathological and healthy tissues, remain poorly understood. To overcome these limitations and to realize the unmet therapeutic opportunities, I will develop and synthesize activity-based probes to selectively target UCHL1, and will apply them to the identification and quantification of UCH enzymes in several cancer cells using activity-based protein profiling. This will provide a unique tool to explore a wide range of DUBs and UCH biology in cells, as well as a starting point to develop selective inhibitors and potential therapeutics. Simultaneously, I will develop and synthesize irreversible PROTACs to selectively degrade UCHL1 and will apply them to quantitatively assess their effect on UCH enzymes in several in vitro cancer and fibrosis models using proteome-wide proteomics experiments. PROTACs are two-headed molecules capable to direct E3 ubiquitin ligase activity towards the target protein, driving its degradation by proteasome. I anticipate that novel PROTACs based on inhibitors that target UCHL1 would provide a unique tool to degrade UCHL1 and prevent deubiquitination, assisting discovery of novel UCHL1 substrates and providing a new paradigm for targeting UCHL1 in disease.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TARGETDUBS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TARGETDUBS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EVERPHOT (2020)

Molecular mechanisms of photoprotection in plants.

Read More  

QS21-Mech (2020)

Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech)

Read More  

MBMsforDOC (2021)

Model-based biomarkers for the characterization and quantification of global states of consciousness

Read More